norgestrel and Venous Thromboembolism
norgestrel has been researched along with Venous Thromboembolism in 9 studies
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors
Authors | Studies |
---|---|
Del Savio, MC; Facchinetti, F; Grandi, G | 1 |
Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK | 1 |
Kelver, ME; Phelps, JY | 1 |
Hagberg, KW; Hernandez, RK; Jick, SS; Kaye, JA | 1 |
Dore, DD; Loughlin, J; Norman, H; Seeger, JD | 1 |
Hagberg, KW; Jick, SS; Kaye, JA | 1 |
Burke, AE; Espey, E; Raymond, EG | 1 |
Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M | 1 |
Mansour, D; Shapiro, S; Szarewski, A | 1 |
Reviews
2 review(s) available for norgestrel and Venous Thromboembolism
Article | Year |
---|---|
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism.
Topics: Animals; Contraceptive Agents, Hormonal; Female; Humans; Levonorgestrel; Norgestrel; Risk; Venous Thromboembolism | 2021 |
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult | 2017 |
Other Studies
7 other study(ies) available for norgestrel and Venous Thromboembolism
Article | Year |
---|---|
Confronting the legal risks of prescribing the contraceptive patch with ongoing litigation.
Topics: Contraceptives, Oral, Combined; Drug Approval; Drug Combinations; Drug Labeling; Ethinyl Estradiol; Gynecology; Humans; Informed Consent; Legislation, Drug; Liability, Legal; Norgestrel; Physicians; United States; Venous Thromboembolism | 2009 |
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.
Topics: Adolescent; Adult; Case-Control Studies; Confidence Intervals; Contraceptives, Oral; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norgestrel; Odds Ratio; Product Surveillance, Postmarketing; United States; Venous Thromboembolism | 2010 |
Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users.
Topics: Administration, Cutaneous; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Myocardial Infarction; Norgestrel; Risk Assessment; Stroke; Venous Thromboembolism | 2010 |
ORTHO EVRA and venous thromboembolism: an update.
Topics: Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Venous Thromboembolism | 2010 |
Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
Topics: Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Labeling; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Assessment; Venous Thromboembolism | 2012 |
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult | 2013 |
Another flawed database study.
Topics: Androstenes; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Venous Thromboembolism | 2013 |